6. Parkinson disease Clinical trials / Disease details
Clinical trials : 2,307 / Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ChiCTR2200056774 | 2022-03-01 | 2022-02-15 | Clinical efficacy and related mechanism of Edaravone and dexborneol in the treatment of newly diagnosed untreated Parkinson's disease patients | Clinical efficacy and related mechanism of Edaravone and dexborneol in the treatment of newly diagnosed untreated Parkinson's disease patients | parkinson’s disease | patient group:Edaravone and dexborneol;Healthy control group:Nil; | nanjing brain hospital | NULL | Recruiting | 30 | 75 | Both | patient group:30;Healthy control group:30; | Phase 4 | China |